Treatment of papillomatosis of the larynx with transfer factor.
D000293:Adolescent; D000328:Adult; D000402:Airway Obstruction / Q000150:complications; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D005350:Fibroma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006168:Guinea Pigs; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007822:Laryngeal Neoplasms / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D027383:Papillomaviridae / Q000302:isolation & purification; D010950:Plasma Cells; D027382:Polyomaviridae; D013601:T-Lymphocytes / Q000187:drug effects; D014165:Transfer Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D014779:Virus Replication
D014165:Transfer Factor